An Ascending, Single Oral Dose Pharmacokinetic Study of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

• Status: Completed
• Trial end date: 1969-12-31

Summary

To characterize the pharmacokinetics of orally administered 3'-deoxy-3'-fluorothymidine (FLT), in a liquid formulation, after single doses in asymptomatic HIV-infected patients and to assess the safety and tolerance of the single oral doses of FLT.

• Phase: N/A

Details

• Lead Sponsor: Lederle Laboratories
• Treatments: Alovudine; Dideoxynucleosides